Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | STAT3 | P40763 | 4/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Harpagide SCHEMBL30132931 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| Harpagide SCHEMBL29385820 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL29727271 | 0.84 | ALDH1A1 (0.71) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL29208523 | 0.84 | ALDH1A1 (0.71) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL29425887 | 0.84 | ALDH1A1 (0.71) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL29425781 | 0.83 | ALDH1A1 (0.49) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL422972 | 0.81 | ALDH1A1 (0.53) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL9057878 | 0.80 | ALDH1A1 (0.51) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| Antirrhinoside SCHEMBL1424987 | 0.79 | ALDH1A1 (0.51) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| Antirrhinoside SCHEMBL27233579 | 0.79 | ALDH1A1 (0.51) | ALDH1A1TSHRKDM4EGLACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 536 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-4379068-B1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | INSTITUT NAT DES SCIENCES APPLIQUEES DE ROUEN (FR) | 2025-06-04 | — | — | EP | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| US-20240343784-A1 | TREATMENT OF MEDICATION OVERUSE HEADACHE USING ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES | H LUNDBECK AS (DK) | 2024-10-17 | — | — | US | claimed |
| EP-4379068-A1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | Institut National Des Sciences Appliquées De Rouen (FR) | 2024-06-05 | — | — | EP | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20230346970-A1 | CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND PSILOCYBIN | SILO PHARMA, INC. | 2023-11-02 | — | — | US | claimed |
| US-20230248838-A1 | CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS | SILO PHARMA, INC. | 2023-08-10 | — | — | US | claimed |
| US-7060693-B1 | Ajuga turkestanica extract and its cosmetic uses | LVMH RECHERCHE (FR) | 2006-06-13 | — | — | US | claimed |
| WO-2006017341-A2 | COATED VAGINAL DEVICES FOR VAGINAL DELIVERY OF THERAPEUTICALLY EFFECTIVE AND/ OR HEALTH-PROMOTING AGENTS | UMD, INC. (US) | 2006-02-16 | — | — | WO | claimed |
| US-20050276836-A1 | Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents | UMD, INC. | 2005-12-15 | — | — | US | claimed |
| EP-1231893-B1 | AJUGA TURKESTANICA EXTRACT AND ITS COSMETIC USES | LVMH RECH (FR) | 2004-08-18 | — | — | EP | claimed |
| US-6531582-B1 | Medicinal plants; herbs; plant extracts; Cibotii rhizoma; use therapy for arthritis, osteoporosis, ruptured disc | Shin, Joon Shik (KR) | 2003-03-11 | — | — | US | claimed |
| WO-2001001996-A9 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIV WESTERN AUSTRALIA (AU) | 2002-09-12 | — | — | WO | claimed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | claimed |
| US-5929038-A | ADMINISTERING IRIDOID COMPOUNDS | CHOONGWAE PHARMACEUTICAL CO., LTD. (KR) | 1999-07-27 | — | — | US | claimed |
| US-5589182-A | AQUEOUS EXTRACTS OF TISSUE OF SPECIFIC CHINESE PLANTS AND HERBS | TASHIRO RENKI (JP) | 1996-12-31 | — | — | US | claimed |
| CN-1082895-A | The Pharmaceutical composition that treatment hepatitis B virus (HBV) infects | CHOONGWAE PHARMA CO LTD (KR) | 1994-03-02 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346970-A1 | CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND PSILOCYBIN | CNR2, NPSR1, CNR1 | ALDH1A1 3677/4885TSHR 4498/4885KDM4E 4639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.